Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia

References

• Andang M, Hjerling-Leffler J, Moliner A, Lundgren TK, Castelo-Branco G, Nanou E, . 2008. Histone H2AX-dependent GABAA receptor regulation of stem cell proliferation. Nature 451:460–464.
   PubMedGoogle Scholar
• Anderson MA, Gusella JF. 1984. Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro 20:856–858.
   PubMedGoogle Scholar
• Arguello PA, Gogos JA. 2008. A signaling pathway AKTing up in schizophrenia. J Clin Invest 118:2018–2021.
   PubMedGoogle Scholar
• Bartek J, Bartkova J, Lukas J. 2007. DNA damage signaling guards against activated oncogenes and tumour progression. Oncogene 26:7773–7779.
   PubMed Web of Science ®Google Scholar
• Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, . 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864–870.
   PubMed Web of Science ®Google Scholar
• Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, . 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633–637.
   PubMed Web of Science ®Google Scholar
• Bassett AS, Scherer SW, Brzustowicz LM. 2010. Copy number variations in schizophrenia: Critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167:899–914.
   PubMed Web of Science ®Google Scholar
• Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M, . 2003. Histone H2AX: A dosage-dependent suppressor of oncogenic translocation and tumors. Cell 114:359–370.
   PubMed Web of Science ®Google Scholar
• Benes FM, Lim B, Subburaju S. 2009. Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolar. Proc Natl Acad Sci USA 106: 11731–11736.
   PubMedGoogle Scholar
• Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. 2008. γH2AX and cancer. Nat Rev Cancer 8:957–967.
   PubMed Web of Science ®Google Scholar
• Burdick KE, DeRosse P, Kane JM, Lencz T, Malhotra AK. 2010. Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability. Am J Psychiatry 167:436–443.
   PubMed Web of Science ®Google Scholar
• Burhans WC, Weinberger M. 2007. DNA replication stress, genome instability and aging. Nucleic Acids Res 35:7545–7556.
   PubMed Web of Science ®Google Scholar
• Cadet JL, Perumal AS. 1990. Chronic treatment with prolixin causes oxidative stress in rat brain. Biol Psychiatry 28: 738–740.
   PubMed Web of Science ®Google Scholar
• Catts VS, Catts SV, McGrath JJ, Feron F, McLean D, Coulson EJ, . 2006. Apoptosis and schizophrenia: A pilot study based on dermal fibroblast cell lines. Schizophr Res 84: 20–28.
   PubMedGoogle Scholar
• Catts VS, Catts SV, O'Toole BI, Frost ADJ. 2008. Cancer incidence in patients with schizophrenia and their first-degree relatives – a meta-analysis. Acta Psychiatr Scand 117: 323–336.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Laursen TM, Mellemkjaer L, Johansen C, Mortensen PB. 2004. Risk for cancer in parents of patients with schizophrenia. Am J Psychiatry 161:903–908.
   PubMedGoogle Scholar
• Emamiam ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. 2004. Convergent evidence for impaired AKT1-GSK3β signalling in schizophrenia. Nat Genet 36:131–137.
   PubMedGoogle Scholar
• Evan GI, Vousden KH. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–348.
   PubMed Web of Science ®Google Scholar
• Feron F, Perry C, Hirning MH, McGrath J, Mackay-Sim A. 1999. Altered adhesion, proliferation and death in neural cultures from adults with schizophrenia. Schizophr Res 40:211–218.
   PubMed Web of Science ®Google Scholar
• Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ. 2010. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies. J Neurol Neurosurg Psychiatry 81:215–221.
   PubMed Web of Science ®Google Scholar
• Forchhammer L, Brauner EV, Folkmann JK, Danielsen PH, Nielsen C, . 2008. Variation in assessment of oxidatively damaged DNA in mononuclear blood cells by the comet assay with visual scoring. Mutagenesis 23:223–231.
   PubMed Web of Science ®Google Scholar
• Frank CL, Tsai L-H. 2009. Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity. Neuron 62:312–326.
   PubMed Web of Science ®Google Scholar
• Guidotti A, Auta J, Davis JM, Dong E, Gavin DP, Grayson DR, . 2011. Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60:1007 1016.
   Google Scholar
• Halazonetis TD, Gorgoulis VG, Bartek J. 2008. An oncogene-induced DNA damage model for cancer development. Science 319:1352–1355.
   PubMed Web of Science ®Google Scholar
• Halicka HD, Huang X, Traganos F, King MA, Dai W, Darzynkiewicz Z. 2005. Histone H2AX phosphorylation after cell irradiation with UV–B. Cell Cycle 4:339–345.
   PubMed Web of Science ®Google Scholar
• Hallmayer JF, Jablensky A, Michie P, Woodbury M, Salmon B, Combrinck J, . 2003. Linkage analysis of candidate regions using a composite neurocognitive phenotype correlated with schizophrenia. Mol Psychiatry 8:511–523.
   PubMedGoogle Scholar
• Hallmayer JF, Kalaydjieva L, Badcock J, Dragovic M, Howell S, Michie PT, . 2005. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet 77:468–476.
   PubMed Web of Science ®Google Scholar
• Harris SL, Gil G, Robins H, Hu W, Hirshfield K, Bond E, . 2005. Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Natl Acad Sci USA 102: 16297–16302.
   PubMed Web of Science ®Google Scholar
• Hickey MA, Chesselet M-F. 2003. Apoptosis in Huntington's disease. Prog Neuro-Psychopharmacol Biol Psychiatry 27: 255–265.
   PubMed Web of Science ®Google Scholar
• Hickson ID. 2003. RecQ helicases: Caretakers of the genome. Nature Rev Cancer 3:169–178.
   PubMed Web of Science ®Google Scholar
• International Schizophrenia Consortium. 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455:237–241.
   PubMed Web of Science ®Google Scholar
• Iourov IY, Vorsanova SG, Liehr T, Yurov YB. 2009. Aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: Differential expression and pathological meaning. Neurobiol Dis 34:212–220.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Bartek J. 2009. The DNA-damage response in human biology and disease. Nature 461:1071–1078.
   PubMed Web of Science ®Google Scholar
• Jacobisiak M, Lasek W, Golab, J. 2003. Natural mechanisms protecting against cancer. Immunol Lett 90:103–122.
   PubMedGoogle Scholar
• Jeste DV, Lohr JB, Manley M. 1992. Study of neuropathological changes in the striatum following 4, 8, and 12 months of treatment with fluphenazine in rats. Psychopharmacology (Berlin) 106:154–160.
   PubMed Web of Science ®Google Scholar
• Kanakry CG, Li Z, Nakai Y, Sei Y, Weinberger DR. 2007. Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-depedent pathway: Potential implications for schizophrenia and cancer. PLoS One 2:e1369.
   PubMed Web of Science ®Google Scholar
• Kataoka Y, Bindokas VP, Duggan RC, Murley JS, Grdina DJ. 2006. Flow cytometric analysis of phosphorylated histone H2AX following exposure to ionizing radiation in human microvascular endothelial cells. J Radiat Res 47:245–257.
   PubMed Web of Science ®Google Scholar
• Khanna KK, Lavin MF, Jackson SP, Mulhern TD. 2001. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 8:1052–1065.
   PubMed Web of Science ®Google Scholar
• Kirov G, O'Donovan MC, Owen MJ. 2005. Finding schizophrenia genes. J Clin Invest 115:1440–1448.
   PubMed Web of Science ®Google Scholar
• Lavin MF. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9:759–769.
   PubMed Web of Science ®Google Scholar
• Lemon JA, Rollo CD, Boreham DR. 2008. Elevated DNA damage in a mouse model of oxidative stress: impacts of ionizing radiation and a protective dietary supplement. Mutagenesis 23:473–482.
   PubMedGoogle Scholar
• Levav I, Lipshitz I, Novikov I, Pugachova I, Kohn R, Barchana M, . 2007. Cancer risk among parents and siblings of patients with schizophrenia. Br J Psychiatry 190:156–161.
   PubMed Web of Science ®Google Scholar
• Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J. 2001. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 58:573–378.
   PubMed Web of Science ®Google Scholar
• MacIntyre DJ, Blackwood DHR, Porteous DJ, Pickard BS, Muir WJ. 2003. Chromosomal abnormalities and mental illness. Mol Psychiatry 8:275–287.
   PubMed Web of Science ®Google Scholar
• Magin GK, Robinson SH, Breslin N, Wyatt RJ, Alexander RC. 1991. DNA repair and mutant frequency in schizophrenia. Mutat Res DNA Repair 255:241–246.
   PubMedGoogle Scholar
• McCurdy RD, Feron F, Perry C, Chant DC, McLean D, Matigian N, . 2006. Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr Res 82: 163–173.
   PubMed Web of Science ®Google Scholar
• Nishioka N, Arnold SE. 2004. Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry 12:167–175.
   PubMedGoogle Scholar
• Olsen JH, Friis S, Frederiksen K, McLaughlin JK, Mellemkjaer L, Moller H. 2005. Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer 92:210–205.
   Google Scholar
• Pazvantoglu O, Selek S, Okay IT, Sengul C, Karabekirglu K, Dilbaz N, Erel O. 2009. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile. Psychiatry Clin Neurosci 63:693–700.
   PubMed Web of Science ®Google Scholar
• Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW. 2010. Cancer and neurodegeneration: Between the devil and the deep blue sea. PLoS Genetics 6:e1001257.
   PubMed Web of Science ®Google Scholar
• Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT-J, Griffin JL. 2004. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684–697.
   PubMed Web of Science ®Google Scholar
• Psimadas D, Messini-Nikolaki N, Zafiropoulou M, Fortos A, Tsilimigaki S, Piperakis SM. 2004. DNA damage and repair efficiency in lymphocytes from schizophrenia patients. Cancer Lett 204:33–40.
   PubMed Web of Science ®Google Scholar
• Roe CM, Fitxpatrick AL, Xiong C, Sieh W, Kuller JP, Miller JP, . 2010. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 74:106–112.
   PubMed Web of Science ®Google Scholar
• Schulz JB, Gerhardt E. 2001. Apoptosis: its relevance to Parkinson's disease. Clin Neurosci Res 427–433.
   Google Scholar
• Shimohama S. 2000. Apoptosis in Alzheimer's disease – an update. Apoptosis 5:9–16.
   PubMed Web of Science ®Google Scholar
• Sorensen SA, Fenger K, Olsen JH. 1999. Significantly lower incidence of cancer among patients with Huntington disease. Cancer 86:1342–1346.
   PubMedGoogle Scholar
• Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462.
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Nossova N, Yager T, Tsuang M-M, Guo S-C, Shyu KG, . 2005. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary report. Am J Med Genet Neuropsychiatr Genet 133B:1–5.
   PubMedGoogle Scholar
• Virit O, Altindag A, Yumru M, Dalkilic A, Savas HA, Selek S, . 2008. A defect in the antioxidant defence system in schizophrenia. Neuropsychobiology 60:87–93.
   Google Scholar
• Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nat Rev Cancer 2:489–501.
   PubMed Web of Science ®Google Scholar
• Wallace SS. 2002. Biological consequences of free-radical-damaged DNA bases. Free Radic Biol Med 33:1–14.
   PubMed Web of Science ®Google Scholar
• Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, . 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. 320:539–543.
   Google Scholar
• Wang L, Lockstone HE, Guest PC, Levin Y, Palotas A, Pietsch S, . 2010. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J Proteome Res 9: 521–527.
   PubMed Web of Science ®Google Scholar
• Weisner RJ, Zsurka G, Kunz WS. 2006. Mitochondrial DNA damage and the aging process – facts and imaginations. Free Radic Res 40:1284–1294.
   PubMedGoogle Scholar
• Wing JK, Babor T, Brugha T, Cooper JE, Jablensky A, Regier D, . 1990. SCAN: Schedule for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47:589–593.
   PubMed Web of Science ®Google Scholar
• Wood SJ, Yucel M, Pantelis C, Berk M. 2009. Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Ann Acad Med Singapore 38:396–401.
   PubMed Web of Science ®Google Scholar
• Young J, McKinney SB, Ross BM, Wahle KWJ, Boyle SP. 2007. Biomarkers of oxidative stress in schizophrenia and control subjects. Prostaglandins Leukot Essent Fatty Acids 76:73–85.
   PubMed Web of Science ®Google Scholar
• Zhang F, Xu Y, Liu P, Fan H, Huang X, Sun G, . 2008. Association analyses of the interaction between the ADSS and ATM genes with schizophrenia in a Chinese population. BMC Med Genet 9:119.
   PubMedGoogle Scholar
• Zhou VW, Goren A, Bernstein BE. 2011. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 12:7–18.
   PubMed Web of Science ®Google Scholar
• Zocchi L, Sassone-Corsi P. 2010. Joining the dots: from chromatin remodelling to neuronal plasticity. Curr Opin Neurobiol 20:432–440.
   PubMedGoogle Scholar